Camille L Bedrosian is a director of Rhythm Pharmaceuticals Inc.
Person profile
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Crinetics Pharmaceuticals, Inc.
11 Jun 24
4
Amylyx Pharmaceuticals, Inc.
18 Apr 24
4
Amylyx Pharmaceuticals, Inc.
29 Nov 23
3
Amylyx Pharmaceuticals, Inc.
29 Nov 23
4
RHYTHM PHARMACEUTICALS, INC.
23 Jun 23
4
Crinetics Pharmaceuticals, Inc.
21 Jun 23
4
Ultragenyx Pharmaceutical Inc.
3 Mar 23
4
Crinetics Pharmaceuticals, Inc.
21 Jun 22
4
RHYTHM PHARMACEUTICALS, INC.
10 Jun 22
4
Ultragenyx Pharmaceutical Inc.
3 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 24 | CRNX Crinetics Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,400 | 0.00 | 9,400 |
7 Jun 24 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 44.71 | 12,500 | 558.88 k | 12,500 |
16 Apr 24 | AMLX Amylyx Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 96,910 | 0.00 | 155,243 |
16 Apr 24 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 120,000 | 241.20 k | 120,000 |
27 Nov 23 | AMLX Amylyx Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 58,333 | 0.00 | 58,333 |
27 Nov 23 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 12.93 | 162,500 | 2.10 mm | 162,500 |
21 Jun 23 | RYTM Rhythm Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 3,000 |
21 Jun 23 | RYTM Rhythm Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 18.47 | 14,000 | 258.58 k | 14,000 |